Literature DB >> 15295414

Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography.

D Vijay Anand1, Eric Lim, Usha Raval, David Lipkin, Avijit Lahiri.   

Abstract

BACKGROUND: Electron beam tomography coronary calcium imaging is an evolving technique for the early detection of coronary atherosclerosis, and recent studies have established its prognostic value in asymptomatic individuals. The relationship of coronary artery calcium scores (CAC) to obstructive coronary artery disease (CAD) has been poorly studied but is clinically relevant because it determines which individuals are likely to benefit from revascularization procedures. Hence, we prospectively evaluated the prevalence of myocardial ischemia in asymptomatic patients with cardiovascular risk factors and subclinical atherosclerosis. METHODS AND
RESULTS: We studied 864 asymptomatic patients with no previous CAD but with cardiovascular risk factors, referred for electron beam tomography coronary calcium imaging to our institution over an 18-month period. From this group, 220 consecutive patients (85% men; mean age, 61 +/- 9 years; age range, 31-84 years) with moderate to severe atherosclerotic disease (coronary calcium score > or =100 Agatston units) were prospectively evaluated by technetium 99m sestamibi single photon emission computed tomography (SPECT). Patients were followed up (mean follow-up, 14 months) and data regarding their subsequent clinical management recorded. Of the 220 patients, 119 had moderate atherosclerosis (CAC score of 100-400 Agatston units) and 101 had severe atherosclerosis (CAC score > or =400 Agatston units). Abnormal SPECT findings were seen in 18% of patients with moderate atherosclerosis (n = 21) and 45% of patients with severe atherosclerosis (n = 45). Increasing severity of atherosclerosis was related to increasing ischemic burden (summed difference score = 1 +/- 0.2 for CAC score of 100-400 Agatston units and 3.2 +/- 0.5 for CAC score > or =400 Agatston units). In a multivariate linear regression model incorporating risk factors, CAC was the only predictor of silent ischemia.
CONCLUSION: In comparison to previously published data, we detected a higher prevalence of silent ischemia even in patients with moderate coronary atherosclerosis (18%). This may reflect the differing risk factor profile of our patient population. When coronary calcium screening is used to preselect asymptomatic patients with cardiovascular risk factors for myocardial perfusion imaging, the optimum coronary calcium score threshold will depend on the population prevalence of risk factors and asymptomatic obstructive CAD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15295414     DOI: 10.1016/j.nuclcard.2004.06.125

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  26 in total

1.  Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality.

Authors:  Leslee J Shaw; Paolo Raggi; Enrique Schisterman; Daniel S Berman; Tracy Q Callister
Journal:  Radiology       Date:  2003-07-17       Impact factor: 11.105

2.  Coronary artery motion during the cardiac cycle and optimal ECG triggering for coronary artery imaging.

Authors:  B Lu; S S Mao; N Zhuang; H Bakhsheshi; H Yamamoto; J Takasu; S C Liu; M J Budoff
Journal:  Invest Radiol       Date:  2001-05       Impact factor: 6.016

3.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

4.  Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients.

Authors:  R Haberl; A Becker; A Leber; A Knez; C Becker; C Lang; R Brüning; M Reiser; G Steinbeck
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

5.  Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.

Authors:  P Soman; R Taillefer; E G DePuey; J E Udelson; A Lahiri
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

6.  Coronary calcium screening in asymptomatic patients as a guide to risk factor modification and stress myocardial perfusion imaging.

Authors:  Kevin W Moser; James H O'Keefe; Timothy M Bateman; Iain A McGhie
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

7.  Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study.

Authors:  J A Rumberger; D B Simons; L A Fitzpatrick; P F Sheedy; R S Schwartz
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

8.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

9.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  26 in total

1.  Complementary roles of coronary calcium scanning and myocardial perfusion SPECT.

Authors:  Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

2.  Patient-centered imaging.

Authors:  E Gordon Depuey; John J Mahmarian; Todd D Miller; Andrew J Einstein; Christopher L Hansen; Thomas A Holly; Edward J Miller; Donna M Polk; L Samuel Wann
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

Review 3.  Relationship between Calcium Score and Myocardial Scintigraphy in the Diagnosis of Coronary Disease.

Authors:  Fabio Paiva Rossini Siqueira; Claudio Tinoco Mesquita; Alair Augusto Sarmet M Damas Dos Santos; Marcelo Souto Nacif
Journal:  Arq Bras Cardiol       Date:  2016-07-18       Impact factor: 2.000

4.  Lack of correlation between coronary artery calcium and myocardial perfusion imaging.

Authors:  Jonathan Rosman; Michael Shapiro; Anuragini Pandey; Andrew VanTosh; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

5.  Computed tomographic imaging within nuclear cardiology.

Authors: 
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

6.  Redefining the low-risk patient with significant atherosclerotic disease.

Authors:  Leslee J Shaw; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

Review 7.  Review of gated SPECT imaging in women with suspected coronary heart disease.

Authors:  Vahini V Naidoo
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

8.  Fourth annual Mario S. Verani, MD Memorial Lecture: noninvasive imaging in coronary artery disease: changing roles, changing players.

Authors:  Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

Review 9.  Cardiac evaluation of liver transplant candidates.

Authors:  Mercedes Susan Mandell; Joann Lindenfeld; Mei-Yung Tsou; Michael Zimmerman
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

10.  Use of coronary calcium scanning for predicting inducible myocardial ischemia: Influence of patients' clinical presentation.

Authors:  Alan Rozanski; Heidi Gransar; Nathan D Wong; Leslee J Shaw; Romalisa Miranda-Peats; Sean W Hayes; John D Friedman; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.